PHARMACOM

What PHARMACOM does

PHARMACOM (legal entity: Pharmacom Handels GmbH) is a Vienna-headquartered pharmaceutical distribution company founded in 2000 that pioneered the Direct-to-Pharmacy (DTP) model in Austria. The company delivers high-value prescription medicines directly from global pharmaceutical manufacturers to registered public pharmacies, eliminating pre-wholesalers and multiple intermediaries from the supply chain. It serves an enterprise client base that includes 5 of the 7 leading global pharmaceutical companies and 7 of the world's top 10 pharmaceutical innovators, operating across Austria, Germany, and Central Europe with stated plans for broader European reach.

The core DTP service is built on Cloey, a proprietary technology platform that provides predictive supply and demand management, order verification, Dynamic Leakage Analysis (DLA), export risk analysis, pharmacy-level BRICS demand analytics, and real-time dashboards and reporting. Cloey integrates with SAP and manufacturer order management systems and supports complementary capabilities including cold-chain and ambient distribution (>99.99% temperature accuracy, <0.01% damage rate), serialization with batch track-and-trace, GDP-certified warehousing, and tailored manufacturer solutions such as patient starter packs, indication tracking, and patient passports. Operations are GDP-certified, with the most recent audit in 2025 yielding zero reclamations.

Revenue is generated through bespoke multi-year B2B contracts with pharmaceutical manufacturers, with quote-based pricing tailored to each partnership; transaction fees on distribution volume are bundled with technology and data services. The go-to-market is sales-led, leveraging direct B2B engagement, a proprietary B2B order system (b2b.pharmacom.at), consultative kick-off calls, and an email-driven inbound channel ([email protected]). In 2024, Pharmacom was acquired by Lacus Legacy, a long-term investment firm co-founded by Paul Szyszkowitz and Christoph Siegesleuthner, who assumed operational leadership as Co-CEOs; original co-founder Axel Binder continues as COO/CTO, Christian Eder transitioned to advisor, and former Pfizer Austria CEO Robin Rumler joined as advisor. The company remains privately held and operates independently of any wholesaler network.

Name

PHARMACOM

Legal name

Pharmacom Handels GmbH

Website

https://pharmacom.at

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

1–10 employees

Short description

PHARMACOM (Pharmacom Handels GmbH) is a Vienna-based Direct-to-Pharmacy pharmaceutical distributor serving leading global pharma manufacturers across Austria, Germany, and Central Europe, using its proprietary Cloey platform for predictive supply management and end-to-end distribution.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution Services

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Warehousing and Storage (493)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Pharmacy Supply Chain & Secondary Distribution (Repackagers/Redistributors) (CRAOAHAC)

akta.pro secondary industry

Pharmacy Logistics, Returns, Reverse Distribution & Compliance Services (CRAOAHAJ)

Keywords

• Pharmaceutical distribution
• Direct-to-pharmacy
• Cold chain logistics
• Pharmaceutical supply chain
• Healthcare logistics

Headquarters

HQ city

Vienna

HQ country

Austria

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Direct-to-Pharmacy Distribution Services: Pharmacom charges pharmaceutical manufacturers for exclusive DTP distribution services, managing the end-to-end delivery of prescription products from manufacturer to pharmacy. Services include demand management, quota control, order processing, cold-chain logistics, serialization compliance, and regulatory quality management.
2. Technology & Data Services: The proprietary Cloey platform provides data insights, real-time dashboards, predictive analytics, and reporting to pharmaceutical manufacturers, likely bundled within the DTP service contract.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

PHARMACOM provides B2B Direct-to-Pharmacy (DTP) pharmaceutical distribution, warehousing, and cold-chain logistics services to pharmaceutical manufacturers across Europe. Distribution is augmented by the proprietary Cloey data platform, which delivers demand forecasting, replenishment, Order Integrity / Dynamic Leakage Analysis, and pharmacy-level reporting. The company also operates a B2B order system and offers tailored solutions for global pharma innovators, including GDP-compliant serialization and regulatory quality management.

Product overview

PHARMACOM operates as a Direct-to-Pharmacy (DTP) distribution company with a platform-based architecture. The core offering is the DTP distribution model powered by the proprietary technology platform 'Cloey', which provides predictive supply and demand management, order verification, and real-time analytics. The B2B Order System enables digital ordering for manufacturers. Additional modules include cold-chain distribution, serialization/track & trace, inventory management, Dynamic Leakage Analysis (DLA), BRICS pharmacy-level data analytics, GDP quality management, warehousing, and tailored solutions for manufacturers including patient programs. The company serves pharmaceutical manufacturers across Austria, Germany, and Central Europe.

Differentiator

Problem solved

Functional benefit

Brands

• Cloey: Proprietary technology system serving as the backbone of predictive supply and demand management for Pharmacom's Direct-to-Pharmacy distribution operations.

Products and services

• Direct-to-Pharmacy (DTP) Distribution B2B Direct-to-Pharmacy pharmaceutical distribution service delivering products from pharmaceutical manufacturers directly to pharmacies across Europe, including cold-chain and ambient capabilities and GDP-compliant serialization.
• Cloey Data & Analytics Platform Proprietary data and analytics platform delivering demand forecasting, predictive replenishment, Order Integrity / Dynamic Leakage Analysis, and pharmacy-level BRICS reporting for pharmaceutical manufacturers.
• B2B Order System Online B2B ordering portal enabling manufacturers and pharmacy partners to place and manage orders against PHARMACOM's distribution platform.
• Cold-Chain & Ambient Distribution Specialised cold-chain and ambient pharmaceutical distribution service for temperature-sensitive biologics and standard pharmaceutical products, provided as a standalone capability.
• Serialization & GDP Quality Management Standalone GDP-certified serialization and regulatory quality management service to help manufacturers meet European pharmaceutical traceability and compliance requirements.
• Tailored Solutions for Manufacturers Bespoke Direct-to-Pharmacy and supply chain solutions designed for individual pharmaceutical manufacturers, delivered by PHARMACOM's specialised sales teams.

Quantifiable outcome

• 100% pharmacy coverage within 24 hours in urgent cold-chain delivery case study (launching to 1,400+ pharmacies)
• +4 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability5 records

Feature6 records

Partnerships

One partnership is on record.

• Binder Pharma Services GmbHminorOthersBinder Pharma Services GmbH acts as a data processor under Art. 28 GDPR for technical maintenance and operational management of the website, including server administration, error monitoring, performance logging, and processing of form submissions. Data processing agreement (DPA) has been concluded.

Scale indicators8 records

Recent moves7 records

Expansion highlights5 records

Regional players

• GEHE Pharma Handel (now part of PHOENIX): Historical German pharmaceutical wholesaler now integrated into PHOENIX Group, with deep wholesale and pharmacy logistics operations in Germany. Relevant as a regional comparable for the German DTP market that Pharmacom is expanding into.

Emerging players

• Redcare Pharmacy (DocMorris): European e-pharmacy and mail-order pharmacy platform with its own B2B distribution capabilities. Relevant as an emerging player operating a more direct, technology-led pharma supply chain model adjacent to Pharmacom's DTP approach.
• Healthcare at Home: Specialty homecare and direct-to-patient pharma service provider focused on cold-chain biologics and specialty medicines. Comparable to Pharmacom on DTP-style delivery to non-traditional points of care (patient/Pharmacy-level reach).

Others

• Movianto (Owens & Minor): European healthcare logistics specialist offering warehousing, cold-chain transport, and distribution services to pharma manufacturers. An adjacent infrastructure provider rather than a direct competitor, but relevant for understanding the contracted logistics layer underlying DTP.

Direct peers

• Alliance Healthcare (Walgreens Boots Alliance): Major European pharmaceutical wholesaler and distributor operating DTP/pre-wholesale models in multiple countries under Walgreens Boots Alliance. Competes head-to-head with Pharmacom for manufacturer DTP contracts in Western and Central Europe.
• Celesio / McKesson Europe: European pharmaceutical distribution arm of McKesson operating full-line wholesale and pharmacy services across Germany, Austria, and other European markets. A relevant peer given Pharmacom's footprint and competition for DTP mandates in AT/DE.
• PHOENIX Group: One of the largest pharmaceutical wholesalers in Europe with broad DTP and pre-wholesale operations across multiple European countries. Directly comparable to Pharmacom as a pharma distribution platform serving manufacturers and pharmacies at scale.

Broad incumbents

• Cardinal Health: Top-3 global pharmaceutical distributor operating at massive scale in the US with manufacturer services and data capabilities. A broad incumbent peer for benchmarking distribution economics and the trajectory of data-enabled pharma distribution.
• McKesson Corporation: Global pharmaceutical distribution leader with US-anchored operations and a European arm through Celesio. While much larger and US-focused, McKesson's pharma distribution business model and global manufacturer relationships make it the leading comparable incumbent.
• Cencora (formerly AmerisourceBergen) / AAH Pharmaceuticals: Global pharmaceutical distributor with a strong European footprint (including AAH in the UK) focused on specialty, DTP, and biopharma services. A broad incumbent whose specialty/DTP business lines directly compete for specialty pharma contracts.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/pharmacomhandelsgmbh
• Instagraminstagram.com/pharmacom.at

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PHARMACOM